NO20010899L - Forbedring av ugunstige apomorfin-effekter - Google Patents
Forbedring av ugunstige apomorfin-effekterInfo
- Publication number
- NO20010899L NO20010899L NO20010899A NO20010899A NO20010899L NO 20010899 L NO20010899 L NO 20010899L NO 20010899 A NO20010899 A NO 20010899A NO 20010899 A NO20010899 A NO 20010899A NO 20010899 L NO20010899 L NO 20010899L
- Authority
- NO
- Norway
- Prior art keywords
- apomorphine
- adverse
- improvement
- effects
- apomorphine effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/138,982 US5994363A (en) | 1998-08-24 | 1998-08-24 | Amelioration of apomorphine adverse effects |
PCT/US1999/014965 WO2000010567A1 (en) | 1998-08-24 | 1999-07-01 | Amelioration of apomorphine adverse effects |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010899D0 NO20010899D0 (no) | 2001-02-22 |
NO20010899L true NO20010899L (no) | 2001-04-24 |
Family
ID=22484576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010899A NO20010899L (no) | 1998-08-24 | 2001-02-22 | Forbedring av ugunstige apomorfin-effekter |
Country Status (14)
Country | Link |
---|---|
US (1) | US5994363A (de) |
EP (1) | EP1105129A4 (de) |
JP (1) | JP2002523370A (de) |
CN (1) | CN1212841C (de) |
AU (1) | AU764068B2 (de) |
BR (1) | BR9913235A (de) |
CA (1) | CA2341673A1 (de) |
CZ (1) | CZ2001610A3 (de) |
HU (1) | HUP0201212A3 (de) |
IL (1) | IL141512A0 (de) |
NO (1) | NO20010899L (de) |
NZ (1) | NZ510359A (de) |
PL (1) | PL346273A1 (de) |
WO (1) | WO2000010567A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050065161A1 (en) * | 1996-02-02 | 2005-03-24 | Nitromed, Inc. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
CN1471395A (zh) | 2000-04-07 | 2004-01-28 | ����ҽҩƷ����˾ | 阿扑***衍生物及其使用方法 |
CA2408399A1 (en) | 2000-05-09 | 2001-11-15 | Nitromed, Inc. | Infrared thermography and methods of use |
DE10043321B4 (de) * | 2000-08-24 | 2005-07-28 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung |
DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
EP1365740A1 (de) * | 2001-02-08 | 2003-12-03 | Pharmacia Corporation | Arzneizmittel mit schnellem wirkungseintritt zur behandlung von sexuellen dysfunktion |
ES2180446B1 (es) * | 2001-07-02 | 2004-01-16 | Esteve Labor Dr | Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil. |
NZ534340A (en) * | 2002-02-07 | 2006-04-28 | Pharmacia Corp | Pharmaceutical dosage form for mucosal delivery |
BR0308567A (pt) * | 2002-03-19 | 2007-01-09 | Michael Holick | derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos |
US7736665B2 (en) * | 2002-05-31 | 2010-06-15 | Titan Pharmaceuticals, Inc. | Implantable polymeric device for sustained release of buprenorphine |
JP2006504795A (ja) * | 2002-10-03 | 2006-02-09 | サイプレス バイオサイエンス, インコーポレイテッド | 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬 |
KR101152183B1 (ko) | 2003-03-31 | 2012-06-15 | 타이탄 파머슈티컬즈 인코퍼레이티드 | 도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스 |
EP1613323A1 (de) * | 2003-04-14 | 2006-01-11 | Vectura Limited | Zubereitungen mit apomorphin zur inhalation |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
US7648995B2 (en) * | 2004-04-13 | 2010-01-19 | The Mclean Hospital Corporation | R(—)-11-hydroxyaporphine derivatives and uses thereof |
US20060083724A1 (en) * | 2004-10-01 | 2006-04-20 | Hilst Todd W | Compositions for the treatment of femal sexual dysfunction |
US7994220B2 (en) | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
US20110111014A1 (en) * | 2007-06-26 | 2011-05-12 | Parkinson's Institute | Methods and compositions for treatment of neurological disorders |
US8431591B2 (en) * | 2007-07-12 | 2013-04-30 | The Mclean Hospital Corporation | R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
DK2952191T3 (en) | 2009-06-12 | 2018-12-10 | Sunovion Pharmaceuticals Inc | Sublingual apomorphine |
CA3115378A1 (en) | 2010-12-16 | 2012-06-21 | Sunovion Pharmaceuticals Inc. | Sublingual films comprising apomorphine and an organic base |
EP2545905A1 (de) * | 2011-07-11 | 2013-01-16 | Britannia Pharmaceuticals Limited | Neue therapeutische Zusammensetzung mit Apomorphin als aktiver Inhaltsstoff |
EP3285771A4 (de) | 2015-04-21 | 2018-12-05 | Sunovion Pharmaceuticals Inc. | Verfahren zur behandlung von morbus parkinson durch verabreichung von apomorphin an eine mundschleimhaut |
IT202100009857A1 (it) | 2021-04-19 | 2022-10-19 | Univ Degli Studi Di Torino | Formulazione a rilascio controllato e prolungato di apomorfina |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2818855A (en) * | 1954-02-11 | 1958-01-07 | Anthony P Miller | Surgical device |
US3976780A (en) * | 1968-07-29 | 1976-08-24 | Societe D'etudes Scientifiques Et Industrielles L'ile-De-France | Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide |
US4127118B1 (en) * | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
US4543256A (en) * | 1982-03-17 | 1985-09-24 | Northeastern University | (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods employing it for inhibiting the effects of epileptic seizures and for prevention and treatment of duodenal ulcers |
AU1508183A (en) * | 1982-06-04 | 1983-12-08 | Beecham Group Plc | Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane |
US4687773A (en) * | 1983-03-28 | 1987-08-18 | Mclean Hospital | (+)-N-N-propylnorapomorphine and selective limbic activity |
US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
US4624965A (en) * | 1984-11-15 | 1986-11-25 | Nastech Pharmaceutical Co., Inc. | Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same |
US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
US4772459A (en) * | 1986-09-09 | 1988-09-20 | Erbamont, Inc. | Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
US4749686A (en) * | 1986-12-04 | 1988-06-07 | New York Medical College | Combinations of renal vasodilators and α1 -adrenergic or ganglionic blocking agents and methods for treating diseases |
US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
US5102887A (en) * | 1989-02-17 | 1992-04-07 | Arch Development Corporation | Method for reducing emesis and nausea induced by the administration of an emesis causing agent |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
EP0978282B1 (de) * | 1994-04-22 | 2005-12-14 | Pentech Pharmaceuticals, Inc. | Sublinguale Zusammensetzung enthaltend Apomorphine zur Diagnose der funktionellen Impotenz |
US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
-
1998
- 1998-08-24 US US09/138,982 patent/US5994363A/en not_active Expired - Fee Related
-
1999
- 1999-07-01 AU AU49651/99A patent/AU764068B2/en not_active Ceased
- 1999-07-01 PL PL99346273A patent/PL346273A1/xx not_active Application Discontinuation
- 1999-07-01 CZ CZ2001610A patent/CZ2001610A3/cs unknown
- 1999-07-01 CN CNB998125210A patent/CN1212841C/zh not_active Expired - Fee Related
- 1999-07-01 JP JP2000565888A patent/JP2002523370A/ja active Pending
- 1999-07-01 CA CA002341673A patent/CA2341673A1/en not_active Abandoned
- 1999-07-01 WO PCT/US1999/014965 patent/WO2000010567A1/en active IP Right Grant
- 1999-07-01 BR BR9913235-4A patent/BR9913235A/pt not_active IP Right Cessation
- 1999-07-01 NZ NZ510359A patent/NZ510359A/xx unknown
- 1999-07-01 HU HU0201212A patent/HUP0201212A3/hu unknown
- 1999-07-01 EP EP99933642A patent/EP1105129A4/de not_active Withdrawn
- 1999-07-01 IL IL14151299A patent/IL141512A0/xx unknown
-
2001
- 2001-02-22 NO NO20010899A patent/NO20010899L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1212841C (zh) | 2005-08-03 |
IL141512A0 (en) | 2002-03-10 |
BR9913235A (pt) | 2001-12-04 |
HUP0201212A2 (en) | 2002-08-28 |
EP1105129A1 (de) | 2001-06-13 |
JP2002523370A (ja) | 2002-07-30 |
AU4965199A (en) | 2000-03-14 |
CA2341673A1 (en) | 2000-03-02 |
HUP0201212A3 (en) | 2004-12-28 |
US5994363A (en) | 1999-11-30 |
EP1105129A4 (de) | 2003-11-12 |
WO2000010567A1 (en) | 2000-03-02 |
CN1324238A (zh) | 2001-11-28 |
CZ2001610A3 (cs) | 2002-03-13 |
NZ510359A (en) | 2003-06-30 |
AU764068B2 (en) | 2003-08-07 |
PL346273A1 (en) | 2002-01-28 |
NO20010899D0 (no) | 2001-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010899L (no) | Forbedring av ugunstige apomorfin-effekter | |
ID29021A (id) | Komposisi galantamina pelepasan terkontrol | |
PT945132E (pt) | Composicao de ibuprofeno | |
ID27092A (id) | Pembuatan ftalat anhidrida | |
CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
ID24638A (id) | Senyawa-senyawa anti aritmia bispidina | |
IS2325B (is) | Örgerðar samsetningar epleróns | |
DE69941116D1 (de) | G von gdf-8 | |
NO992165D0 (no) | Forbedret fremstilling av isoprenoider | |
CY2006003I1 (el) | Χρηση δαπτομυκινης | |
EE200100246A (et) | Asendatud fenüültsükloheksüülühendite uued esterderivaadid | |
NO20011083L (no) | Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH | |
ID24374A (id) | Komposisi-komposisi parenteral alatrofloksasin | |
TR199903132A3 (tr) | Metalosan bilesiklerinin aktive edici kompozisyonu. | |
DE69906921D1 (de) | Erweiterung des Farbtonumfangs | |
ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
ID16838A (id) | Komposisi dekafluoropentana | |
FI964570A (fi) | Puheluiden yhdistäminen | |
ID24327A (id) | Produksi senyawa-senyawa avermektin | |
PT1175417E (pt) | Compostos substituidos de benzolactamas | |
ID23757A (id) | Komposisi bahan penyempurna | |
ID17419A (id) | Komposisi dekafluoropentana | |
ID23032A (id) | Komposisi insektisida | |
FI980469A0 (fi) | Arrangemang foer faestande av en begraensningsstaong vid en dragstaong |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |